Search
for
Sort by
Research 661–690 of 1000+
- Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease
- Association between Alopecia Areata, Psoriasis Vulgaris, Thyroid Disease, and Metabolic Syndrome
- Association of epidemiological and biochemical factors with premature graying of hair: A case–control study
- Alopecia Areata
- Identification of blood microRNA alterations in patients with severe active alopecia areata
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Under Development JAK Inhibitors for Dermatologic Diseases
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
- Probiotics in Dermatology: An Evidence-based Approach
- The Link Between Obesity and the Skin
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Proopiomelanocortin (POMC) and Psychodermatology
- Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens
- Phototherapy for alopecia areata
- Autophagy: Guardian of Skin Barrier
- Cardiovascular Disease-Associated Skin Conditions
- A Review of the Most Common Dermatologic Conditions and their Debilitating Psychosocial Impacts
- Osteopontin: a new facilitating factor in alopecia areata pathogenesis?
- Baricitinib for the Treatment of Alopecia Areata
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Essential Role of STAT3 Signaling in Hair Follicle Homeostasis
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Prevalence and treatment of Alopecia areata in Taif area, KSA
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
- Hair diseases: a big problem on a small surface
- Advances in Nanocarrier Systems for Dermatologic Transdermal Drug Delivery: A Chemical and Molecular Review